Muzastotug
Phase 1Biologic
Muzastotug is one of 5 biologic programs targeting Advanced Microsatellite Stable Colorectal Carcinoma. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Advanced Microsatellite Stable Colorectal Carcinoma
#DrugCompanyPhaseTrials
1Camptosar
PfizerPhase 1
Adrucil
EElorac, Inc.
Phase 1
Navmi
SSummit Therapeutics
Phase 1
Wellcovorin
EEastern Cooperative Oncology Group
Phase 1
Muzastotug
CCity of Hope Medical Center
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Muzastotug. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 1[1]
- Company
- CCity of Hope Medical Center